
Long-term culturing of stem cells may improve the treatment of respiratory conditions.

Restriction spectrum imaging distinguishes between different prostate cancer tumor grades.

Proteogenomic analysis expands knowledge into breast cancer therapy.

Top articles of the week on The American Journal of Pharmacy Benefits.

Top articles of the week on Specialty Pharmacy Times.

Chronic obstructive pulmonary disease patients who use opioids face a higher risk of respiratory-related death.

Recent advances and updates in oncology and cancer drug development.

Approximately 2 million Hispanics living in Texas are uninsured.

Eight genes expressed in glioblastoma tumors that can predict the survival time of the patient.

Prescription drug costs projected to decline through 2025.

Resistance and endurance exercises may improve muscle growth and repair in multiple sclerosis patients.

Robotic trainer rectum helps teach providers to better detect prostate cancer.

Top news of the day from across the health care landscape.

Efavirenz may aid in the breakdown and removal of cholesterol from the brain in Alzheimer’s disease patients.

Hops could lower risk of breast cancer in post-menopausal women.

Patient navigators found to enhance adherence to screening guidelines in ethnic minority and less fortunate cancer patients.

Systemic sclerosis affects the connective tissue of the skin and internal organs.

Multiple myeloma cells show greater ability to spread in obese and morbidly obese patients.

Evidence builds supporting the use of fecal transplants to treat infections in the gut microbiome.

Regular physical activity is effective lowering the risk of diabetes, but some patients do not see improved insulin sensitivity.

Researchers establish new criteria to diagnose functional gastrointestinal disorders.

Top news of the day from across the health care landscape.

Discovery may lead to new treatments for colon cancer.

New analysis may lead to the development of new antiviral HIV drugs.

Surgeons were able to remove 29% of additional tumors using OTL38.

US cancer centers spent $173 million on advertising in 2014.

Avelumab is an experimental, full human anti-PD-L1 Ig G1 monoclonal antibody.

Levels of good and bad gut bacteria influences autoimmune disease.

Women averaging 60-hour work weeks found to be at greater risk for a number of chronic diseases.

Tenofovir disoproxil fumarate and emtricitabine administered via a sustained release intravaginal ring shows promise treating (S)HIV.